This inventor holds 1 USPTO granted patent, plus 1 CIPO patent and 1 EPO patent. Top assignee: Pfizer Corporation. Active years: 2014.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2014
Title: Isao Sakurada: Innovator in Pharmaceutical Chemistry
Introduction
Isao Sakurada is a notable inventor based in Chita, Japan. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that target various medical conditions. His work has implications for treating a range of disorders, showcasing his expertise and dedication to innovation.
Latest Patents
Sakurada holds a patent for benzisoxazole derivatives, which are compounds designed to address conditions mediated by 5-HT receptor activity. This invention includes a formula that can be utilized in the treatment of gastroesophageal reflux disease, gastrointestinal diseases, and various neurological disorders, among others. His patent is a testament to his commitment to advancing medical science and improving patient outcomes.
Career Highlights
Throughout his career, Isao Sakurada has been associated with Pfizer Corporation, a leading global pharmaceutical company. His role at Pfizer has allowed him to collaborate with other talented professionals in the industry, further enhancing his contributions to pharmaceutical research and development.
Collaborations
Sakurada has worked alongside esteemed colleagues such as Hirohide Noguchi and Chikara Uchida. These collaborations have fostered an environment of innovation and have led to the development of groundbreaking pharmaceutical solutions.
Conclusion
Isao Sakurada's work in the field of pharmaceutical chemistry exemplifies the impact of innovative thinking on healthcare. His patent for benzisoxazole derivatives highlights his commitment to addressing complex medical challenges. Through his career at Pfizer and collaborations with other experts, Sakurada continues to contribute to advancements in medicine.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
